Likely active: new fund Feb 2024 Verified 4 Nov 2026
Agent Capital
Waltham, MA healthcare venture firm investing in novel therapeutics across all stages of development, in areas such as oncology, immunology, neurology and rare disease.
- Type
- VC firm
- Location
- Waltham, Massachusetts, United States
- Stages
- Seed, Growth
- Backs
- Biotech and pharma
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- $100M Agent Capital Fund II (Form D offering, 2021)
- Latest fund or filing
- 18 Feb 2026
- Portfolio mix
- Biotech and pharma 90%; Medtech and digital health 7%; Consumer products 3% (n=30)
- Website
- www.agentcapital.com
Fund filings (SEC Form D)
- Latest fund on file
- Agent Capital Fund III
- Filed
- 18 Feb 2026 (amendment)
- Fund size
- $100M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Agent Capital, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Affini-T
Sources
- www.sec.gov/Archives/edgar/data/2012338/000201233826000003/
- adviserinfo.sec.gov/firm/summary/288532
- www.agentcapital.com
- www.agentcapital.com/portfolio/
- www.agentcapital.com/contact/
- www.sec.gov/Archives/edgar/data/1862081/000186208121000002/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 22 lists
Growth-stage investors in Massachusetts (18)Biotech investors in Massachusetts (37)Growth-stage biotech investors in the US (44)Healthtech investors in Massachusetts (58)Seed investors in Massachusetts (60)Growth-stage biotech investors (109)Growth-stage healthtech investors in the US (121)Seed biotech investors in the US (159)Venture capital firms in Massachusetts (185)Growth-stage investors in the US (288)Biotech venture capital firms in the US (297)Seed biotech investors (300)Growth-stage healthtech investors (316)Seed healthtech investors in the US (437)Biotech investors (484)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Seed investors in the US (1,043)Healthtech investors (1,207)Seed investors (1,892)Venture capital firms in the US (2,975)